Qi Bin Liang
Direttore Tecnico/Scientifico/R&S presso GENOR BIOPHARMA HOLDINGS LIMITED
Profilo
Qi Bin Liang is the founder of CMAB BioPharma (Suzhou) Inc. He is currently working as the Chief Technology Officer at Genor Biopharma Holdings Ltd.
He completed his graduate degree from the University of Idaho and his undergraduate degree from East China University of Science & Technology.
Posizioni attive di Qi Bin Liang
| Società | Posizione | Inizio |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Direttore Tecnico/Scientifico/R&S | 01/10/2021 |
CMAB BioPharma (Suzhou) Inc.
 CMAB BioPharma (Suzhou) Inc. Miscellaneous Commercial ServicesCommercial Services CMAB BioPharma (Suzhou) Inc. develops and manufactures biological products. Its services include process development, GMP manufacturing, aseptic drug and quality development. The company was founded by Qibin Liang in June 2017 and is headquartered in Suzhou, China. | Fondatore | - |
Formazione di Qi Bin Liang
| East China University of Science & Technology | Undergraduate Degree |
| University of Idaho | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
CMAB BioPharma (Suzhou) Inc.
CMAB BioPharma (Suzhou) Inc. Miscellaneous Commercial ServicesCommercial Services CMAB BioPharma (Suzhou) Inc. develops and manufactures biological products. Its services include process development, GMP manufacturing, aseptic drug and quality development. The company was founded by Qibin Liang in June 2017 and is headquartered in Suzhou, China. | Commercial Services |
- Borsa valori
- Insiders
- Qi Bin Liang
